![]() ![]() Make any changes to a patient’s insulin regimen under close medical supervision with increased frequency of blood glucose monitoring. Repeated insulin injections into areas of lipodystrophy or localized cutaneous amyloidosis have been reported to result in hyperglycemia and a sudden change in the injection site (to an unaffected area) has been reported to result in hypoglycemia. Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen: Changes in an insulin regimen (e.g., insulin strength, manufacturer, type, or injection site or method of administration) may affect glycemic control and predispose to hypoglycemia or hyperglycemia.Sharing poses a risk for transmission of blood-borne pathogens. Patients using Levemir ® vials should never share needles or syringes with another person. Never Share a Levemir ® FlexPen ® prefilled pen, Needle, or Syringe Between Patients: Levemir ® FlexPen ® prefilled pens must never be shared between patients, even if the needle is changed.Levemir ® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to insulin detemir or any of the excipients in Levemir ®.Important Safety Information Contraindications Levemir ® is not recommended for the treatment of diabetic ketoacidosis. Levemir ® (insulin detemir) injection 100 U/mL is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.Card activation is required.Indications and Usage for Levemir ® (insulin detemir) injection 100 U/mL ![]() Offer void where prohibited by law and subject to change or discontinue without notice. This offer is invalid for patients whose prescription claims for Covered Insulin are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE ®/CHAMPUS, or any State Patient or Pharmaceutical Assistance Program. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. ![]() Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate annual cap of $16,000. Patients may pay as little as $35 per prescription per month for a 30-day supply of your Covered Insulin. Subject to additional terms and conditions, which can be found This offer is invalid for patients without commercial drug insurance or whose prescription claims for Covered Insulin are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE ®/CHAMPUS, or any State Patient or Pharmaceutical Assistance Program. Patients must have commercial drug insurance to pay as little as $35 per prescription per month for a 30-day supply of your Covered Insulin. Terms, conditions, and limitations apply to the Savings Card. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |